The following are commonly associated with phlebitis when given via the intravenous route:
Rationale:
Potassium chloride is commonly associated with phlebitis when administered intravenously. Its high osmolarity can irritate the vein lining, leading to inflammation and discomfort. Additionally, the concentrated nature of potassium chloride increases the likelihood of venous trauma, further exacerbating phlebitis risk.
B: Hydrocortisone Generally used for its anti-inflammatory properties, hydrocortisone does not possess the same irritative qualities as potassium chloride and is less likely to induce phlebitis.
C: Diazepam Typically administered intramuscularly or orally, diazepam has a lower association with phlebitis when given intravenously, as it does not cause significant vein irritation.
D: 50 per cent glucose While hypertonic, 50 per cent glucose does not share the same high irritation potential as potassium chloride and is less frequently linked to phlebitis in intravenous applications.
Which of the following is a True statement?
Rationale:
B: Theophylline is a drug with saturation kinetics and narrow therapeutic index. This statement is accurate as theophylline exhibits non-linear pharmacokinetics, meaning its metabolism can become saturated, leading to potential toxicity within a narrow therapeutic range.
A: Acetylation is a phase I reaction. This statement misclassifies acetylation, which is a conjugation process typically considered a phase II reaction, where drugs are modified for excretion.
C: A constant amount of a drug with 1st-order kinetics is eliminated per unit time. This statement misrepresents 1st-order kinetics, where a constant fraction of the drug is eliminated over time, not a fixed amount.
D: Steady-state plasma concentration of drugs with zero-order kinetics is achieved after 4 t1/2. This statement inaccurately suggests a timeframe for zero-order kinetics; steady-state is reached based on the rate of infusion, not a specific half-life multiplier.
The rate of drug bioavailability is most rapid when the drug is formulated as a
Rationale:
D: Solution. The rate of drug bioavailability is most rapid when a drug is formulated as a solution because it is already in liquid form, allowing for immediate absorption into the bloodstream without the need for disintegration or dissolution processes.
A: Controlled - release product. These formulations are designed to release the drug slowly over time, which delays absorption and reduces the initial peak concentration in the bloodstream.
B: Hard gelatin capsule. While these capsules can be effective, they require time for the gelatin to dissolve before the drug can be absorbed, slowing the onset of bioavailability.
C: Compressed tablet. Compressed tablets must first disintegrate and dissolve before the active ingredient can be absorbed, which slows the overall rate of bioavailability compared to a solution.
A medical student is doing a summer research project studying five antibiotics to determine potency using the EC50. Antibiotics are placed in plated culture wells with 100,000 CFU of Escherichia coli. The EC50 results for the five antibiotics are shown in the following choices. Based on the results, the most potent antibiotic is
Rationale:
B: Antibiotic B EC50 = 2. This value indicates that Antibiotic B effectively reduces the growth of Escherichia coli at a much lower concentration than the other antibiotics, demonstrating its superior potency.
A: Antibiotic A EC50 = 100. This higher EC50 value suggests that Antibiotic A requires a significantly greater concentration to achieve the same effect, indicating lower effectiveness against the bacteria.
C: Antibiotic C EC50 = 80. With an EC50 of 80, this antibiotic also needs a higher concentration to be effective compared to Antibiotic B, reflecting reduced potency.
D: Antibiotic D EC50 = 20. Though better than A and C, this value still shows that Antibiotic D is less potent than Antibiotic B, requiring more concentration to inhibit bacterial growth.
A 79-year-old man with end-stage Alzheimer's disease and dysphagia is taking multiple medications. Physical examination reveals xerostomia and a limited gag reflex. Which of the following routes of medication administration would provide the lowest serum drug concentration?
Rationale:
Enteral. Administering medications enterally in a patient with dysphagia leads to reduced absorption due to xerostomia and compromised gag reflex, resulting in the lowest serum drug concentration among the options provided.
B: Intramuscular. This route allows for quicker absorption into the bloodstream, leading to higher serum concentrations than enteral administration, especially in patients with swallowing difficulties.
C: Intrathecal. Medications delivered intrathecally bypass systemic circulation, directly entering the central nervous system, resulting in higher concentrations than those achieved through enteral routes.
D: Intravenous. This method provides immediate access to the bloodstream, ensuring the highest serum drug concentrations, which contrasts with the enteral approach in patients with swallowing issues.
Which of the following terms best describes a co-factor that is firmly bound to an apoenzyme?
Rationale:
B: Prosthetic group A prosthetic group is a tightly bound co-factor to an apoenzyme, essential for its function. This term specifically highlights the stable association required for enzymatic activity, distinguishing it from other forms of co-factors that may not be as firmly attached.
A: Holoenzyme A holoenzyme refers to the complete active form of an enzyme, including its apoenzyme and all necessary co-factors, rather than specifically indicating a firmly bound co-factor.
C: Coenzyme A coenzyme generally denotes a loosely associated co-factor that assists in the enzyme's activity but does not imply a permanent, stable attachment, which is characteristic of a prosthetic group.
D: Transferase Transferases are enzymes that catalyze the transfer of functional groups between molecules, not a term describing a co-factor's binding characteristics in relation to an apoenzyme.
The following drugs are absorbed predominantly through active transport systems:
Rationale:
Levodopa is absorbed predominantly through active transport systems. This drug utilizes specific transport mechanisms in the gastrointestinal tract to ensure effective passage across cell membranes, allowing it to reach the central nervous system efficiently.
A: Paracetamol (acetaminophen) Primarily absorbed through passive diffusion, paracetamol does not rely on active transport systems, which limits its uptake efficiency compared to drugs that utilize these specialized mechanisms.
B: Phenytoin This anticonvulsant is absorbed mainly via passive diffusion, making it less reliant on transport systems than levodopa, which specifically requires active transport for optimal absorption and delivery.
D: Methyldopa While methyldopa is absorbed in the gastrointestinal tract, it does not primarily depend on active transport systems, unlike levodopa, which employs these mechanisms to enhance its bioavailability and therapeutic effectiveness.
The passage of drug molecules from a region of high drug concentration to a region of low drug concentration is known as
Rationale:
The passage of drug molecules from a region of high drug concentration to a region of low drug concentration is known as simple diffusion.
Simple diffusion accurately describes the movement of molecules down their concentration gradient without the need for energy expenditure, facilitating the process of drug absorption. This passive transport mechanism is essential in pharmacokinetics, allowing drugs to reach their target sites effectively.
A: Active transport This process requires energy to move molecules against their concentration gradient, which does not align with the passive nature of the described movement.
B: Bioavailability Refers to the proportion of a drug that enters systemic circulation unchanged, not the mechanism of drug movement between concentration gradients.
C: Biopharmaceutics Focuses on the relationship between the physical and chemical properties of drugs and their dosage forms, rather than describing molecular movement between concentration areas.
Once they have been metabolized by the liver, the metabolites may be:
Rationale:
Once they have been metabolized by the liver, the metabolites may be: all of the above. Metabolites can exhibit varying degrees of activity compared to the parent drug, making them either more active, less active, or completely inactivated, thus allowing for diverse biological responses and facilitating their eventual excretion without any pharmacological effect.
A: More active than the parent drug. Some metabolites may enhance therapeutic effects, leading to increased activity compared to the original compound, which is a common phenomenon in drug metabolism.
B: Less active than the parent drug. Certain metabolites can possess diminished efficacy, resulting in reduced pharmacological action when compared to the original drug structure following liver metabolism.
C: Totally “deactivated” so that they are excreted without any effect. Metabolism can lead to complete inactivation of some drugs, ensuring that they are eliminated from the body without exerting any further impact.
Which cellular structure stores hormones and other substances?
Rationale:
The Golgi apparatus stores hormones and other substances.
This structure is essential for processing and packaging proteins and lipids, allowing for the storage and transport of hormones. It modifies these substances for secretion or delivery to other cellular destinations, ensuring proper hormonal regulation and cellular function.
B: Endoplasmic reticulum This organelle primarily synthesizes proteins and lipids rather than storing them, playing a crucial role in initial processing rather than the final storage or packaging stages.
C: Mitochondria These organelles are responsible for energy production through cellular respiration. Their primary function involves ATP synthesis, not the storage of hormones or other substances.
D: Lysosome Lysosomes specialize in breaking down waste materials and cellular debris. Their role focuses on digestion and recycling within the cell, not on hormone or substance storage.
Two different pain meds are given together for pain relief. The drug-drug interaction is:
Rationale:
Two different pain meds are given together for pain relief. The drug-drug interaction is synergistic. This means that the combined effect of the medications is greater than the sum of their individual effects, enhancing pain relief more effectively than either drug alone, thus providing superior therapeutic benefits in managing pain.
B: Antagonistic Interaction implies that one drug diminishes the effect of the other, which contradicts the intended combined relief effect of the medications.
C: Potentiative Suggests that one drug enhances the effects of the other, but this term is less specific than "synergistic" and does not fully capture the interaction's nature.
D: Additive Indicates that the effects of the drugs simply sum up, which does not highlight the greater effectiveness achieved through their combined action compared to their individual contributions.
The following can reduce GFR:
Rationale:
C: Iodine-containing contrast media can reduce GFR. This occurs due to the potential for renal vasoconstriction and toxicity associated with the contrast agents, which can impair kidney function and decrease glomerular filtration rate.
A: Naproxen Nonsteroidal anti-inflammatory drugs like naproxen typically do not have a direct effect on GFR reduction, as their primary action involves pain relief and inflammation reduction rather than renal impairment.
B: Ranitidine This medication primarily acts as an H2 blocker to reduce stomach acid. It does not have a significant influence on kidney function or GFR levels in typical clinical scenarios.
D: Lisinopril As an ACE inhibitor, lisinopril is known to potentially improve GFR by promoting vasodilation of the efferent arterioles in the kidneys, thereby enhancing renal blood flow and function.
Drugs that are receptor agonists may demonstrate what property?
Rationale:
Drugs that are receptor agonists may demonstrate desensitization or down-regulation with continuous use. This occurs as the body's homeostatic mechanisms adapt to prolonged stimulation, leading to reduced receptor sensitivity or availability.
A: Irreversible binding to the drug receptor site involves permanent attachment, which does not characterize receptor agonists that typically allow for reversible interactions.
B: Up-regulation with chronic use refers to an increase in receptor numbers, which occurs with antagonists, not agonists, that continuously stimulate the receptor.
D: An inverse relationship between drug concentration and drug action suggests that higher concentrations lead to reduced effects, contradicting the expected response of agonists that typically increase effect with concentration.
The following is common between aspirin and other NSAIDs
Rationale:
A: Reversibly inhibit COX enzyme. Aspirin irreversibly inhibits COX enzymes, while other NSAIDs typically provide reversible inhibition. This fundamental difference distinguishes aspirin from the common action of NSAIDs regarding COX inhibition.
B: Prolonged antiplatelet effect. While aspirin does have a prolonged antiplatelet effect, this characteristic is not universally shared with other NSAIDs, limiting the commonality between them.
C: Prophylaxis against myocardial infarction. Aspirin is specifically recognized for its role in myocardial infarction prevention, a unique application not applicable to the broader category of NSAIDs.
Paclitaxel (a taxane):
Rationale:
Paclitaxel causes sensory neuropathies. This side effect arises due to its mechanism of action, which disrupts microtubule function, leading to damage in peripheral nerves and resulting in various sensory disturbances in patients.
A: May be used alone or in combination for a broad range of epitheloid tumours and lymphomas. While paclitaxel is versatile, this statement doesn't address the specific adverse effects associated with its use.
B: Inhibits purine synthesis. Paclitaxel does not interfere with purine synthesis; instead, it targets microtubules, making this option irrelevant to its pharmacological profile.
D: Requires glucocorticosteroid premedication to minimize acute hypersensitivity reactions. Although premedication may be needed for some chemotherapeutics, this is not a requisite for paclitaxel specifically, highlighting a misconception.
A mucosal protective agent for long term prophylaxis for NSAID- ulcer
Rationale:
Colloidal bismuth serves as a mucosal protective agent effective for long-term prophylaxis against NSAID-induced ulcers by enhancing mucosal defense mechanisms and promoting healing of the gastric lining.
A: Sucralfate This agent primarily acts by forming a protective barrier over ulcers but is not specifically indicated for long-term prophylaxis against NSAID-induced ulcers.
C: Misoprostol Although it protects the gastric mucosa, its primary use is for preventing NSAID-induced ulcers rather than serving as a long-term prophylactic agent.
D: None of the above This option dismisses the available agents that effectively provide protection against NSAID-induced ulcers, especially colloidal bismuth, which is suitable for long-term use.
Uses of clarithromycin include:
Rationale:
Clarithromycin is used to treat Mycoplasma pneumoniae infections. This bacterium is a common cause of atypical pneumonia, and clarithromycin’s effectiveness against it makes it a suitable choice for treatment in such cases.
B: Legionnaire's disease. Clarithromycin is not the primary treatment for this severe pneumonia, typically requiring other antibiotics, such as azithromycin or levofloxacin, for effective management.
C: Campylobacter enteritis. Although clarithromycin can be used for some gastrointestinal infections, it is not the standard treatment for Campylobacter, which is often managed with other antibiotics like ciprofloxacin.
D: Non-specific urethritis. Clarithromycin does not target the usual pathogens responsible for non-specific urethritis, such as Chlamydia trachomatis, which is more effectively treated with azithromycin or doxycycline.
The pharmacokinetic 'elimination half-life' of the following drugs mirrors their pharmacodynamic duration and intensity of action:
Rationale:
C: Dobutamine exhibits a pharmacokinetic elimination half-life that closely aligns with its pharmacodynamic effects, providing a reliable duration and intensity of action for managing heart failure and shock.
A: Salbutamol has a shorter elimination half-life, leading to a rapid onset and offset of action, which does not consistently reflect its pharmacodynamic duration or intensity.
B: Phenelzine's elimination half-life is prolonged, but its pharmacodynamic effects are not directly proportional, as it primarily functions as an irreversible MAO inhibitor with varying clinical responses.
D: Omeprazole's half-life does not correspond with its pharmacodynamic activity, as it has a delayed effect on gastric acid secretion that does not align with its elimination characteristics.
Represents rate & extent of drug absorption as measured by area under curve
Rationale:
Bioavailability (F) represents the rate and extent of drug absorption as measured by the area under the curve. It quantifies the proportion of a drug that enters systemic circulation, reflecting how much of the administered dose reaches the bloodstream effectively, which is essential for understanding a drug's therapeutic potential.
A: Systemic clearance (CLs) Measures the efficiency of drug elimination from the body, focusing on how quickly a drug is removed rather than its absorption characteristics.
B: Volume of distribution (Vd) Indicates how extensively a drug disperses throughout body tissues relative to the plasma concentration, not the absorption process itself.
C: Half-life (t1/2) Refers to the time needed for the drug concentration to decrease by half, providing no direct insight into the absorption rate or extent.
An advantage of prescribing a sublingual medication is that the medication is:
Rationale:
Absorbed rapidly. Sublingual medications enter the bloodstream directly through the mucous membranes under the tongue, allowing for faster onset of action compared to conventional oral medications that must pass through the digestive system first.
B: Excreted rapidly. While some medications may be excreted swiftly, sublingual administration focuses on absorption speed, not elimination, which does not characterize its primary advantage.
C: Metabolized minimally. Although sublingual medications may experience less first-pass metabolism, this option misrepresents the primary benefit of rapid absorption, which is more significant in clinical settings.
D: Distributed equally. The distribution of sublingual medications is influenced by various factors including blood flow and tissue permeability, making equal distribution an inaccurate description of their pharmacokinetics.
Cross MATCH each drug to its specific adverse effect: Bran/Psyllium
Rationale:
Intestinal obstruction if not taken with plenty of fluids. Bran/Psyllium can absorb water and swell, which may lead to blockages in the digestive tract if not enough fluids are consumed alongside it.
B: Mutagenic. This option does not pertain to Bran/Psyllium, which is primarily a fiber supplement known for its gastrointestinal effects rather than genetic alterations.
C: Lipid pneumonia. This adverse effect is typically associated with the inhalation of oils, not with Bran/Psyllium, which is taken orally and does not pose such risks.
D: Flatulence & aggravation of diabetes. While some fiber supplements may cause flatulence, Bran/Psyllium’s primary concern is intestinal obstruction, not a significant aggravation of diabetes symptoms.
The initial distribution of a drug into tissue is determined chiefly by the
Rationale:
The rate of blood flow to tissue determines the initial distribution of a drug into tissue. Enhanced blood flow facilitates a quicker delivery of the drug, influencing its concentration in various tissues effectively.
B: Glomerular filtration rate (GFR) Primarily affects renal clearance rather than the initial distribution of drugs into tissues, making it less relevant for understanding tissue drug concentration.
C: Stomach emptying time Relates to the absorption of drugs but does not influence how quickly a drug distributes into tissues following administration into the bloodstream.
D: Affinity of the drug for tissue Impacts the equilibrium and retention of the drug within tissues over time, rather than the immediate distribution phase after administration.
Pretreatment with propranolol will block which one of the following?
Rationale:
Pretreatment with propranolol will block norepinephrine-induced bradycardia. Propranolol, a non-selective beta-blocker, inhibits the effects of norepinephrine on the heart, preventing the decrease in heart rate associated with bradycardia.
A: Methacholine-induced tachycardia. Methacholine primarily acts on muscarinic receptors, not adrenergic receptors, rendering propranolol ineffective in countering the resultant increase in heart rate.
B: Nicotine-induced hypertension. Nicotine acts on nicotinic receptors, leading to increased blood pressure independently of the beta-adrenergic pathways that propranolol influences.
D: Phenylephrine-induced mydriasis. Phenylephrine is an alpha-1 adrenergic agonist that causes pupil dilation through a different mechanism, unaffected by propranolol's beta-blocking properties.
The following drugs may be administered transcutaneously to produce their systemic therapeutic effect:
Rationale:
D: Fentanyl
Transcutaneous administration of Fentanyl is effective due to its high lipophilicity, allowing it to penetrate the skin and reach systemic circulation quickly, providing rapid analgesic effects without invasive methods.
A: Glyceryl trinitrate (GTN)
While GTN can be absorbed transcutaneously, its primary use is for localized vasodilation, not systemic therapeutic effects, limiting its efficacy in broader therapeutic applications compared to Fentanyl.
B: Estradiol
Though Estradiol can be delivered transcutaneously, its primary role focuses on hormonal replacement rather than producing immediate systemic therapeutic effects like analgesia, which Fentanyl accomplishes effectively.
C: Lidocaine (lignocaine)
Lidocaine is primarily utilized for local anesthetic effects, and while it can be absorbed transcutaneously, it does not provide the systemic therapeutic benefits associated with Fentanyl's analgesic properties.
Lipophilicity reduces
Rationale:
Lipophilicity reduces renal excretion. Increased lipophilicity enhances the ability of substances to cross biological membranes, making them less likely to be excreted through the kidneys, thus retaining them in the body longer.
A: Absorption Lipophilicity typically increases absorption by promoting passive diffusion across lipid membranes, enhancing the overall bioavailability of compounds rather than reducing it.
B: Volume of distribution (Vd) Higher lipophilicity often results in a greater volume of distribution, as lipophilic drugs tend to accumulate in fatty tissues and other compartments, not diminishing distribution.
C: Hepatic elimination Lipophilicity can enhance hepatic metabolism, leading to increased elimination from the body rather than a reduction, as the liver processes lipophilic substances effectively.
A 19-year-old female has a history of absence seizures. She currently takes ethosuximide to control her symptoms. The process of eliminating this drug involves multiple steps of metabolism followed by excretion. Many organs take part in both metabolism as well as excretion of drugs. Which of the following describes a step of metabolism?
Rationale:
Acetaminophen glucuronidation by enterocytes describes a step of metabolism. This process involves the conjugation of acetaminophen with glucuronic acid, facilitating its conversion into a more water-soluble compound for easier excretion from the body. The enterocytes play a crucial role in processing drugs, demonstrating the metabolic transformation essential to drug elimination.
B: Digoxin actively transported from hepatocytes into bile involves excretion rather than metabolism, as it refers to the removal of the drug from the liver to the digestive system.
C: Ethanol passing from the blood into the alveoli represents diffusion rather than metabolism, focusing on the movement of substances between compartments without any biochemical transformation occurring.
D: Pancuronium being filtered in the kidney pertains to excretion processes, highlighting the elimination of the drug from the bloodstream rather than undergoing metabolic changes in the body.
All of the following statements about plasma protein binding of a drug are true except
Rationale:
Displacement of a potent drug that is normally more than 95% bound may cause toxicity.
Drugs that are highly bound to plasma proteins typically exhibit a lower volume of distribution (V_D) compared to those that bind extensively to tissues, as tissue binding allows for greater distribution throughout the body.
A: Displacement of a drug from plasma protein binding sites leads to a temporary rise in free drug levels but does not directly correlate with increased V_D.
B: Displacement enhances the availability of unbound drug for kidney filtration, yet this does not inherently affect the volume of distribution in the body.
C: Displacement of a drug that is over 95% bound increases free drug levels, potentially resulting in heightened effects or toxicity, but does not impact V_D directly.
The following is not true concerning tricyclic antidepressant toxicity:
Rationale:
C: Atropine toxicity is seldom seen. Tricyclic antidepressant toxicity primarily leads to symptoms such as convulsions and arrhythmias, while atropine toxicity is not typically associated with or a common concern in this context.
A: Arrhythmia is managed by NaHCO3. Sodium bicarbonate is indeed used to treat arrhythmia caused by tricyclic antidepressants, particularly due to its ability to stabilize cardiac conduction.
B: Convulsions is one of the features of toxicity. Convulsions are a well-documented manifestation of tricyclic antidepressant toxicity, highlighting the neurotoxic effects these medications can have in overdose situations.
D: Conduction defects are responsible for the arrhythmia. Arrhythmias in tricyclic antidepressant toxicity result from drug effects on cardiac ion channels, not solely from conduction defects, making this statement misleading.
A medical student is involved in a summer research project evaluating the excitatory and inhibitory effects of five neurotransmitters. Following as choices are the five neurotransmitters and their excitatory and inhibitory status. Which of the following neurotransmitters is likely to be serotonin?
Rationale:
Serotonin is likely to be Neurotransmitter C; excitatory and inhibitory.
This option accurately reflects serotonin's dual role in the central nervous system, where it can enhance or suppress neuronal activity, influencing various physiological and psychological processes, including mood regulation and anxiety.
A: Neurotransmitter A; excitatory. This option fails to recognize serotonin's inhibitory capabilities, overlooking its significant role in inhibiting certain neuronal pathways and affecting mood and emotional responses.
B: Neurotransmitter B; excitatory. This choice disregards the nuanced functions of serotonin, which are not exclusively excitatory and encompass important inhibitory effects on neurotransmission and neural circuits.
D: Neurotransmitter D; inhibitory. While serotonin has inhibitory functions, this option neglects its excitatory role, misrepresenting the complexity of serotonin's actions in various brain regions and its overall influence on mood and behavior.
Used to describe drugs with identical areas under the curve (AUCs)
Rationale:
D: Bioequivalence ratio describes drugs that produce the same systemic exposure, indicated by identical areas under the curve (AUCs). This term is essential in pharmacokinetics to ensure therapeutic equivalence between formulations.
A: Systemic clearance (CLs) quantifies the efficiency of drug elimination from the body rather than focusing on the similarity of AUCs between different drugs.
B: Volume of distribution (Vd) represents the distribution of the drug throughout body fluids and tissues, which does not directly relate to the concept of identical AUCs.
C: Half-life (t1/2) refers to the time taken for the plasma concentration of a drug to reduce by half, not a measure of AUC similarity among different drugs.
The following are commonly associated with phlebitis when given via the intravenous route:
Rationale:
Potassium chloride is commonly associated with phlebitis when administered intravenously. Its high osmolarity and irritant properties can lead to inflammation and irritation of the venous wall, resulting in phlebitis.
B: Hydrocortisone This steroid is generally well-tolerated when given intravenously and does not typically cause irritation or inflammation of the vein, making it less associated with phlebitis.
C: Diazepam When administered intravenously, diazepam can cause local irritation, but it is not as strongly linked to phlebitis as potassium chloride due to its formulation and delivery method.
D: 50 per cent glucose High concentrations of glucose can cause irritation, but it is not a primary cause of phlebitis compared to potassium chloride, which is more frequently associated with venous inflammation.
Which of the following is a True statement?
Rationale:
Theophylline is a drug with saturation kinetics and narrow therapeutic index. This statement is accurate as theophylline exhibits non-linear pharmacokinetics at higher doses, leading to potentially dangerous plasma levels within a narrow therapeutic range.
A: Acetylation is a phase I reaction. Acetylation is classified as a phase II reaction, involving the conjugation of drugs to form more water-soluble compounds for elimination.
C: A constant amount of a drug with 1st-order kinetics is eliminated per unit time. In first-order kinetics, the elimination rate is proportional to the drug concentration, resulting in a variable amount eliminated over time.
D: Steady-state plasma concentration of drugs with zero-order kinetics is achieved after 4 t1/2. Zero-order kinetics lead to a constant amount eliminated over time, making steady-state concentration dependent on total dose, not half-life.
The rate of drug bioavailability is most rapid when the drug is formulated as a
Rationale:
D: Solution. The rate of drug bioavailability is most rapid with solutions because they are already in a dissolved state, allowing for immediate absorption into the bloodstream without the need for disintegration or dissolution.
A: Controlled - release product. This formulation is designed for gradual release over time, which slows the absorption rate and can delay the onset of action compared to immediate-release forms.
B: Hard gelatin capsule. While effective for delivery, hard gelatin capsules require dissolution before absorption can occur, which inherently slows down the bioavailability compared to a solution.
C: Compressed tablet. Compressed tablets need to disintegrate and dissolve before the active ingredient can be absorbed, leading to a slower onset of action compared to liquid forms like solutions.
A medical student is doing a summer research project studying five antibiotics to determine potency using the EC50. Antibiotics are placed in plated culture wells with 100,000 CFU of Escherichia coli. The EC50 results for the five antibiotics are shown in the following choices. Based on the results, the most potent antibiotic is
Rationale:
B: Antibiotic B EC50 = 2
This option indicates that Antibiotic B requires a lower concentration to inhibit 50% of the bacterial growth, demonstrating its higher potency compared to the other antibiotics listed.
A: Antibiotic A EC50 = 100
This antibiotic necessitates a significantly larger concentration to achieve the same effect, indicating reduced effectiveness against Escherichia coli compared to Antibiotic B.
C: Antibiotic C EC50 = 80
The higher EC50 value suggests that more of Antibiotic C is needed to reach the 50% inhibition level, rendering it less potent than Antibiotic B.
D: Antibiotic D EC50 = 20
With an EC50 of 20, this antibiotic has moderate potency; however, it still falls short of the superior effectiveness exhibited by Antibiotic B.
A 79-year-old man with end-stage Alzheimer's disease and dysphagia is taking multiple medications. Physical examination reveals xerostomia and a limited gag reflex. Which of the following routes of medication administration would provide the lowest serum drug concentration?
Rationale:
Enteral. This route typically involves administration through feeding tubes or orally, which can lead to reduced absorption rates and lower serum drug concentrations, particularly in patients with dysphagia and xerostomia.
B: Intramuscular. This method allows for quicker absorption into the bloodstream, resulting in higher serum concentrations compared to enteral administration.
C: Intrathecal. This route delivers medication directly into the cerebrospinal fluid, yielding significantly higher serum drug concentrations than enteral methods.
D: Intravenous. This administration provides immediate access to the bloodstream, ensuring rapid and high serum concentrations of the medication, which contrasts sharply with enteral absorption rates.
Which of the following terms best describes a co-factor that is firmly bound to an apoenzyme?
Rationale:
B: Prosthetic group. A prosthetic group is a non-polypeptide unit that is tightly and permanently attached to an enzyme, enhancing its activity and stability, which is essential for proper enzyme function.
A: Holoenzyme. A holoenzyme refers to the complete active form of an enzyme that includes both the apoenzyme and any associated co-factors or coenzymes, but does not specify tight binding.
C: Coenzyme. A coenzyme is a loosely attached organic molecule that assists in enzyme activity, typically released and regenerated during reactions, contrasting with the firmly bound nature of a prosthetic group.
D: Transferase. Transferase describes a class of enzymes that catalyze the transfer of functional groups between molecules, not referring to the binding characteristics of co-factors in enzymes.
The following drugs are absorbed predominantly through active transport systems:
Rationale:
C: Levodopa. Levodopa is primarily absorbed through active transport systems, utilizing specific transporters in the gut and blood-brain barrier, which are crucial for its effective therapeutic action in Parkinson's disease.
A: Paracetamol (acetaminophen) Absorption occurs mainly via passive diffusion, not requiring active transport systems, making it distinct from drugs that rely on specific transport mechanisms for uptake.
B: Phenytoin Primarily absorbed through passive diffusion mechanisms, phenytoin does not utilize active transport systems, leading to differences in its pharmacokinetics compared to drugs that depend on active transport.
D: Methyldopa While it can be absorbed through transport systems, methyldopa is predominantly taken up via passive diffusion, lacking the reliance on active transport mechanisms seen in levodopa.
The passage of drug molecules from a region of high drug concentration to a region of low drug concentration is known as
Rationale:
The passage of drug molecules from a region of high drug concentration to a region of low drug concentration is known as simple diffusion.
Simple diffusion is a fundamental process where molecules move spontaneously from areas of higher concentration to lower concentration, relying solely on concentration gradients without requiring energy, making it essential in pharmacokinetics for drug distribution in the body.
A: Active transport involves the movement of molecules against their concentration gradient, utilizing energy, which contradicts the passive nature of the diffusion process described.
B: Bioavailability refers to the extent and rate at which the active ingredient or active moiety is absorbed and becomes available at the site of action, not the mechanism of movement between concentrations.
C: Biopharmaceutics focuses on the relationship between the physical and chemical properties of drugs and their dosage forms, not specifically on the passive movement of molecules between different concentration areas.
Once they have been metabolized by the liver, the metabolites may be:
Rationale:
Once they have been metabolized by the liver, the metabolites may be all of the above. Metabolites can exhibit various activities; they might be more active, less active, or completely deactivated, influencing their pharmacological effects and excretion routes. This variability illustrates the complexity of drug metabolism and its implications for therapeutic outcomes.
A: More active than the parent drug Metabolites can exhibit enhanced activity compared to their original compounds, potentially leading to increased efficacy or unexpected side effects in therapeutic settings.
B: Less active than the parent drug Some metabolites may possess diminished efficacy, resulting in reduced therapeutic impact and necessitating careful consideration of dosing and treatment strategies based on metabolic pathways.
C: Totally “deactivated” so that they are excreted without any effect Certain metabolites are rendered completely inactive, ensuring that they can be safely eliminated from the body without contributing to pharmacological effects or toxicity.
Which cellular structure stores hormones and other substances?
Rationale:
The Golgi apparatus stores hormones and other substances.
This organelle processes, sorts, and packages proteins and lipids synthesized in the endoplasmic reticulum, preparing them for secretion or delivery to various cellular destinations, effectively managing hormone storage and release.
B: Endoplasmic reticulum Lacks the specialized function of storage; instead, it primarily focuses on synthesizing proteins and lipids, playing a critical role in cellular metabolism rather than storage.
C: Mitochondria Primarily responsible for energy production through cellular respiration, mitochondria do not engage in storage activities related to hormones or other substances, focusing on ATP generation instead.
D: Lysosome Functions mainly in digestion and waste processing within cells, lysosomes contain enzymes for breaking down cellular debris and do not serve as storage sites for hormones or substances.
Two different pain meds are given together for pain relief. The drug-drug interaction is:
Rationale:
Two different pain meds are given together for pain relief. The drug-drug interaction is synergistic. This means that the combined effect of the medications is greater than the sum of their individual effects, providing enhanced pain relief through their interaction, which can lead to better management of symptoms for patients requiring stronger analgesic effects.
B: Antagonistic This option suggests that the drugs counteract each other, which would reduce overall effectiveness. In this scenario, the medications work together rather than opposing one another.
C: Potentiative While this term implies that one drug enhances the effect of another, it doesn't accurately describe the interaction of two different medications working synergistically to produce a combined effect.
D: Additive This option indicates that the effects of the drugs simply add up, but does not capture the enhanced interaction that occurs when two medications produce a greater effect together than individually.
The following can reduce GFR:
Rationale:
C: Iodine-containing contrast media can reduce GFR. This reduction occurs due to the potential for contrast-induced nephropathy, which can impair renal function and lead to decreased glomerular filtration rates during imaging procedures.
A: Naproxen Nonsteroidal anti-inflammatory drugs like naproxen can affect kidney function, but they typically do not have as direct and immediate an impact on GFR as contrast media.
B: Ranitidine As an H2 blocker, ranitidine primarily affects gastric acid secretion and does not significantly influence glomerular filtration rate or renal perfusion under normal circumstances.
D: Lisinopril While lisinopril is an ACE inhibitor that can influence renal blood flow, it generally helps to preserve GFR rather than reduce it, especially in hypertensive patients.
Drugs that are receptor agonists may demonstrate what property?
Rationale:
Receptor agonists may demonstrate desensitization or down-regulation with continuous use. This phenomenon occurs as the receptor's response diminishes over time due to prolonged stimulation, leading to reduced sensitivity or number of receptors available for activation.
A: Irreversible binding to the drug receptor site. This characteristic typically applies to antagonists or certain drugs that permanently alter receptor functionality, rather than agonists that activate receptors.
B: Up-regulation with chronic use. This process generally occurs with antagonists, where receptor numbers increase to compensate for inhibition, contrasting with the down-regulation associated with receptor agonists.
D: Inverse relationship between drug concentration and drug action. Agonists typically exhibit a direct relationship, where increased concentration leads to enhanced receptor activation, not an inverse correlation affecting drug efficacy.
The following is common between aspirin and other NSAIDs
Rationale:
D: Hypersensitivity reactions may occur. Both aspirin and other NSAIDs can trigger allergic responses in certain individuals, including skin rashes, asthma exacerbations, and gastrointestinal disturbances, highlighting a shared risk profile among these medications.
A: Reversibly inhibit COX enzyme. Aspirin irreversibly inhibits the COX enzyme, while many NSAIDs act through reversible mechanisms, making this statement an inaccurate generalization about their pharmacological behavior.
B: Prolonged antiplatelet effect. Aspirin uniquely provides a lasting antiplatelet effect due to its irreversible COX inhibition, distinguishing it from other NSAIDs that do not share this property.
C: Prophylaxis against myocardial infarction. Aspirin is specifically used for cardiovascular protection, whereas other NSAIDs do not have the same role in preventing myocardial infarction, indicating a significant difference in their applications.
Paclitaxel (a taxane):
Rationale:
Paclitaxel causes sensory neuropathies. This side effect arises due to the drug's mechanism of action, which disrupts microtubule function, leading to nerve damage and sensory disturbances in patients receiving treatment.
A: May be used alone or in combination for a broad range of epitheloid tumours and lymphomas. While paclitaxel is versatile, its primary association is not with lymphomas, limiting this assertion's accuracy.
B: Inhibits purine synthesis. Paclitaxel does not affect purine synthesis; instead, its primary role involves stabilizing microtubules, making this option a misrepresentation of the drug's mechanism.
D: Requires glucocorticosteroid premedication to minimize acute hypersensitivity reactions. Although premedication is common for some chemotherapies, paclitaxel does not universally necessitate glucocorticosteroid use for hypersensitivity management, making this statement misleading.
A mucosal protective agent for long term prophylaxis for NSAID- ulcer
Rationale:
Colloidal bismuth serves as a mucosal protective agent, effectively promoting long-term prophylaxis against NSAID-induced ulcers by adhering to the ulcer site, stimulating mucus and bicarbonate production, and exhibiting antimicrobial properties.
A: Sucralfate This agent primarily acts by forming a protective barrier over ulcers but lacks the broader prophylactic benefits against NSAID-related gastric damage provided by colloidal bismuth.
C: Misoprostol While effective for ulcer prevention, its primary mechanism involves enhancing mucosal defense rather than the protective and reparative properties that colloidal bismuth offers for NSAID-induced ulcers.
D: None of the above This option dismisses the valid role of colloidal bismuth, which is specifically designed for the long-term prevention of ulcers associated with NSAID usage, unlike the alternatives.
Uses of clarithromycin include:
Rationale:
Clarithromycin is effective in treating Mycoplasma pneumoniae infections. This antibiotic targets respiratory pathogens, particularly those resistant to other treatments, making it a suitable choice for addressing atypical pneumonia caused by this bacterium.
B: Legionnaire's disease Clarithromycin is not the primary treatment for Legionnaire's disease, which is typically caused by Legionella pneumophila and often requires different antibiotic therapies for effective management.
C: Campylobacter enteritis While clarithromycin can have some efficacy against Campylobacter species, it is not the standard treatment, as other antibiotics are preferred for this gastrointestinal infection.
D: Non-specific urethritis Clarithromycin is not the first-line treatment for non-specific urethritis, which is often treated with other antibiotics more specifically targeted at common causative agents.
The pharmacokinetic 'elimination half-life' of the following drugs mirrors their pharmacodynamic duration and intensity of action:
Rationale:
C: Dobutamine's pharmacokinetic elimination half-life aligns closely with its pharmacodynamic effects, resulting in a duration and intensity of action that is predictable and manageable during therapeutic use, particularly in heart failure management.
A: Salbutamol's action duration does not consistently correlate with its elimination half-life, as its rapid onset and offset can lead to variable effects in clinical settings, particularly in asthma treatment.
B: Phenelzine's half-life does not directly reflect its therapeutic effects, as its antidepressant action may persist beyond its elimination due to complex interactions with neurotransmitter systems and receptor dynamics.
D: Omeprazole's pharmacokinetic profile involves prolonged gastric acid suppression that exceeds its elimination half-life, indicating that its therapeutic effects may last longer than the drug's presence in the system.
Represents rate & extent of drug absorption as measured by area under curve
Rationale:
Bioavailability (F) quantifies the rate and extent of drug absorption, represented by the area under the plasma concentration-time curve, indicating how much of the administered drug reaches systemic circulation.
A: Systemic clearance (CLs) measures the efficiency of drug elimination from the body, not the absorption characteristics or extent of drug presence in systemic circulation.
B: Volume of distribution (Vd) reflects the distribution of a drug throughout the body's compartments, lacking direct correlation with absorption rates and extent in systemic circulation.
C: Half-life (t1/2) defines the time required for drug concentration to reduce by half, focusing on elimination rather than the absorption rate and extent of drug availability.
An advantage of prescribing a sublingual medication is that the medication is:
Rationale:
Absorbed rapidly. Sublingual medications enter the bloodstream quickly through the tissues under the tongue, bypassing the digestive system, which leads to faster onset of action compared to other forms of administration.
B: Excreted rapidly. This option focuses on the elimination process rather than the absorption characteristics that define the advantage of sublingual medication.
C: Metabolized minimally. While sublingual routes can reduce first-pass metabolism, this choice does not highlight the speed of absorption, which is the primary benefit.
D: Distributed equally. Distribution refers to how a drug disperses throughout the body, not the initial absorption rate, making this option irrelevant to the rapid action of sublingual medications.
Cross MATCH each drug to its specific adverse effect: Bran/Psyllium
Rationale:
Intestinal obstruction if not taken with plenty of fluids. Bran/Psyllium absorbs water to form a gel-like substance, which can lead to blockage in the intestines without adequate hydration, making this effect relevant.
B: Mutagenic. Psyllium does not have mutagenic properties; it primarily acts as a bulk-forming laxative and is generally considered safe for these uses without causing genetic damage.
C: Lipid pneumonia. This condition is typically associated with the aspiration of oils or fats, not with the use of Bran/Psyllium, which is a fiber supplement and not an oily substance.
D: Flatulence & aggravation of diabetes. While fiber can cause flatulence, it does not typically aggravate diabetes; in fact, it may help regulate blood sugar levels when consumed appropriately.
The initial distribution of a drug into tissue is determined chiefly by the
Rationale:
The rate of blood flow to tissue determines the initial distribution of a drug into tissue. This flow influences how quickly and effectively the drug can reach its target areas, impacting therapeutic efficacy.
B: Glomerular filtration rate (GFR) focuses on renal clearance rather than initial tissue distribution, making it less relevant in the early phases of drug action.
C: Stomach emptying time primarily affects drug absorption rather than distribution into tissues, thus not influencing how quickly a drug reaches its target sites post-administration.
D: Affinity of the drug for tissue plays a role in binding once the drug reaches the tissue, but it does not govern the initial distribution process itself.
Pretreatment with propranolol will block which one of the following?
Rationale:
Pretreatment with propranolol will block norepinephrine-induced bradycardia. Propranolol, a non-selective beta-blocker, inhibits the action of norepinephrine on beta-adrenergic receptors, effectively reducing heart rate and preventing bradycardia.
A: Methacholine-induced tachycardia. This option involves muscarinic receptor activation, which propranolol does not target; thus, it cannot prevent tachycardia caused by methacholine.
B: Nicotine-induced hypertension. Nicotine primarily stimulates nicotinic receptors, and propranolol does not interfere with this pathway, allowing hypertension to occur.
D: Phenylephrine-induced mydriasis. Phenylephrine acts on alpha-1 adrenergic receptors to induce pupil dilation, a process that propranolol does not influence, leaving mydriasis unaffected.
The following drugs may be administered transcutaneously to produce their systemic therapeutic effect:
Rationale:
D: Fentanyl
Fentanyl is a potent opioid analgesic commonly administered transcutaneously for systemic therapeutic effects, providing effective pain relief while minimizing gastrointestinal side effects often associated with oral medications. Its patch formulation ensures steady drug release over time, enhancing patient compliance and comfort in managing acute and chronic pain conditions.
A: Glyceryl trinitrate (GTN) Transcutaneous administration of GTN primarily targets localized vascular conditions, rather than achieving systemic therapeutic effects, limiting its efficacy compared to other systemic agents like fentanyl.
B: Estradiol Estradiol is typically delivered via transdermal patches for hormone replacement therapy, but its primary focus is on localized hormonal regulation, rather than producing the broader systemic effects associated with fentanyl.
C: Lidocaine (lignocaine) While lidocaine can be administered transcutaneously for localized anesthesia, it does not achieve the systemic therapeutic effects necessary for comprehensive pain management, distinguishing it from fentanyl's capabilities.
Lipophilicity reduces
Rationale:
Lipophilicity reduces renal excretion. Increased lipophilicity allows drugs to diffuse easily through cell membranes, leading to greater reabsorption in renal tubules and decreased elimination in urine.
A: Absorption Lipophilicity enhances absorption as lipophilic substances readily penetrate biological membranes, increasing the likelihood of reaching systemic circulation effectively.
B: Volume of distribution (Vd) Higher lipophilicity typically increases the volume of distribution, allowing drugs to disperse widely throughout body tissues rather than limiting their distribution.
C: Hepatic elimination Lipophilicity generally promotes hepatic elimination, as lipophilic compounds are often metabolized in the liver, enhancing their clearance from the bloodstream rather than reducing it.
A 19-year-old female has a history of absence seizures. She currently takes ethosuximide to control her symptoms. The process of eliminating this drug involves multiple steps of metabolism followed by excretion. Many organs take part in both metabolism as well as excretion of drugs. Which of the following describes a step of metabolism?
Rationale:
Acetaminophen glucuronidation by enterocytes describes a step of metabolism. This process involves the conversion of acetaminophen into a more water-soluble form through glucuronidation, facilitating its excretion from the body.
B: Digoxin actively transported from hepatocytes into bile involves excretion rather than metabolism, as it relates to the elimination of the drug rather than its chemical transformation.
C: Ethanol passing from the blood into the alveoli pertains to gas exchange and does not involve metabolic modification of the substance itself, thus not representing a metabolic step.
D: Pancuronium being filtered in the kidney signifies a process of elimination rather than metabolism, as it describes the removal of the drug from circulation without any prior biochemical alteration.
All of the following statements about plasma protein binding of a drug are true except
Rationale:
Drugs that are highly bound to plasma proteins generally have a lower V_D compared to those that are not, as extensive protein binding restricts the drug's distribution into tissues.
A: Displacement of a drug from plasma protein binding sites results in a transient increased volume of distribution (V_D) shows that displacement can lead to more drug available in circulation, affecting distribution.
B: Displacement of a drug from plasma protein binding sites makes more free drug available for glomerular filtration highlights that increased free drug enhances renal elimination, influencing pharmacokinetics positively.
C: Displacement of a potent drug that is normally more than 95% bound may cause toxicity emphasizes the risk of sudden increases in free drug concentrations, potentially leading to adverse effects.
The following is not true concerning tricyclic antidepressant toxicity:
Rationale:
C: Atropine toxicity is seldom seen. Tricyclic antidepressant toxicity typically manifests through symptoms like arrhythmias and convulsions, while atropine-related issues are not commonly associated with this specific drug toxicity profile.
A: Arrhythmia is managed by NaHCO3. This statement is misleading as NaHCO3 is not the primary treatment for arrhythmias caused by tricyclic antidepressant toxicity, which requires different management approaches.
B: Convulsions is one of the features of toxicity. Convulsions are indeed a recognized symptom of tricyclic antidepressant toxicity, thus affirming the presence of serious neurological complications associated with overdose.
D: Conduction defects are responsible for the arrhythmia. While conduction defects can occur, they are not the sole mechanism causing arrhythmias in tricyclic antidepressant toxicity, making this statement overly simplistic.
A medical student is involved in a summer research project evaluating the excitatory and inhibitory effects of five neurotransmitters. Following as choices are the five neurotransmitters and their excitatory and inhibitory status. Which of the following neurotransmitters is likely to be serotonin?
Rationale:
Serotonin is likely to be Neurotransmitter C; excitatory and inhibitory. This classification reflects serotonin's complex role in the central nervous system, where it can promote or suppress neuronal firing depending on the receptor subtype it interacts with, thus influencing various physiological processes including mood, anxiety, and sleep.
A: Neurotransmitter A; excitatory. This option suggests a purely excitatory function, which does not encompass serotonin's dual role in modulating neuronal activity, overlooking its inhibitory effects.
B: Neurotransmitter B; excitatory. Similar to option A, this choice fails to recognize serotonin's inhibitory capabilities, indicating an incomplete understanding of its multifaceted neurotransmission properties.
D: Neurotransmitter D; inhibitory. This selection inaccurately limits serotonin to only inhibitory functions, neglecting its excitatory effects and the context of its diverse physiological roles in the brain.
Used to describe drugs with identical areas under the curve (AUCs)
Rationale:
Bioequivalence ratio (E) describes drugs that have the same areas under the curve (AUCs), indicating that they produce similar drug exposure in the body. This concept is critical in assessing therapeutic equivalence between different formulations.
A: Systemic clearance (CLs) Relates to the rate at which a drug is eliminated from the body, not directly measuring AUC equivalence between different drugs.
B: Volume of distribution (Vd) Indicates the extent of drug distribution in body tissues, but does not assess or compare AUCs between different pharmacological agents.
C: Half-life (t1/2) Refers to the time taken for drug concentration to reduce by half, but it does not imply equivalence in AUC between different drugs.